Beclomethasone dipropionate, formoterol (Innuvair)
Beclomethasone dipropionate, formoterol
Safeline Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Safeline Pharmaceuticals (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Innuvair inhaler EACH METERED DOSE CONTAINS BECLOMETHASONE DIPROPIONATE 100,0 ug FORMOTEROL FUMARATE 6,0 ug | Inhaler | 42089542/21.5.1/0895 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Beclomethasone dipropionate
- except when intended for inhalation or nasal administration.
Consolidated Schedules 06 July 2026, line 5441
S4: Formoterol
Consolidated Schedules 06 July 2026, line 6443
S3: Beclomethasone dipropionate
- when intended for inhalation or nasal administration, except when intended for nasal administration as an aqueous spray, other than by pressurised aerosol, and indicated for the treatment of the symptoms of seasonal allergic rhinitis (hay fever) in adults and children over 12 years of age, subject to
- a maximum dose of 100 micrograms per nostril and a maximum daily dose of 200 micrograms of per nostril and
- a maximum pack size of 200 doses. (S2, S4)
Consolidated Schedules 06 July 2026, lines 3170 to 3177
S2: Beclomethasone dipropionate
- when intended for nasal administration as an aqueous spray, other than by pressurised aerosol, and indicated for the treatment of the symptoms of seasonal allergic rhinitis (hay fever) in adults and children over 12 years of age, subject to
- a maximum dose of 100 micrograms per nostril and a maximum daily dose of 200 micrograms of per nostril and
- a maximum pack size of 200 doses. (S3, S4)
Consolidated Schedules 06 July 2026, lines 1647 to 1654
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.